Sponsor:
Weill Medical College of Cornell University
Code:
NCT07764744
Conditions
Ovarian Neoplasms
BRCA 1 Gene Mutation
BRCA 2 Gene Mutation
Serous Tubal Intraepithelial Carcinoma
Early Detection of Ovarian Cancer
Eligibility Criteria
Sex: Female
Age: 35+
Healthy Volunteers: Not accepted
Interventions
Galleri Multi-Cancer Early Detection (MCED) Blood Test
Brief summary:
Conditions
Ovarian Neoplasms
BRCA 1 Gene Mutation
BRCA 2 Gene Mutation
Serous Tubal Intraepithelial Carcinoma
Early Detection of Ovarian Cancer
Study ID
NCT07764744
Start date
Oct 7, 2026
Status verified date
Nov, 2026
Completion date
Oct, 2039
Anticipated
Primary completion date
Oct, 2039
Anticipated
Eligibility Criteria
Sex: Female
Age: 35+
Healthy Volunteers: Not accepted
Enrollment
70 participants
Anticipated
Allocation
Non randomized
Intervention Model
Single group
Primary purpose
Diagnostic
Arms
experimental: Cohort A: BRCA1/2 Surgical Feasibility Cohort
experimental: Cohort B: STIC Longitudinal Surveillance Cohort
Interventions
Galleri Multi-Cancer Early Detection (MCED) Blood Test
Primary outcome measure
Central contacts
Locations
Weill Cornell Medicine
Recruiting
New York, New York, United States, 10065
Contacts
Principal Investigator:
Melissa K Frey, MD, MS
Sponsor
Weill Medical College of Cornell University
Last update posted
Nov 18, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by Weill Medical College of Cornell University on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.